80 related articles for article (PubMed ID: 25821229)
1. Changes in BCG Vaccination Policy Should Consider the Effect on Child Health.
Thysen SM; Aaby P; Benn CS; Fisker AB
J Infect Dis; 2015 Oct; 212(8):1341-2. PubMed ID: 25821229
[No Abstract] [Full Text] [Related]
2. Delayed BCG vaccination--time to take a shot.
Kay AW; Blish CA
J Infect Dis; 2015 Feb; 211(3):335-7. PubMed ID: 25108029
[No Abstract] [Full Text] [Related]
3. Reply to Thysen et al.
Tchakoute CT; Hesseling AC; Blakney AK; Jaspan HB
J Infect Dis; 2015 Oct; 212(8):1342-3. PubMed ID: 25821228
[No Abstract] [Full Text] [Related]
4. Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T-cell responses in HIV-exposed infants.
Tchakoute CT; Hesseling AC; Kidzeru EB; Gamieldien H; Passmore JA; Jones CE; Gray CM; Sodora DL; Jaspan HB
J Infect Dis; 2015 Feb; 211(3):338-46. PubMed ID: 25108027
[TBL] [Abstract][Full Text] [Related]
5. BCG vaccination induces HIV target cell activation in HIV-exposed infants in a randomized trial.
Gasper MA; Hesseling AC; Mohar I; Myer L; Azenkot T; Passmore JS; Hanekom W; Cotton MF; Crispe IN; Sodora DL; Jaspan HB
JCI Insight; 2017 Apr; 2(7):e91963. PubMed ID: 28405623
[No Abstract] [Full Text] [Related]
6. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
7. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
Mazzola TN; da Silva MT; Abramczuk BM; Moreno YM; Lima SC; Zorzeto TQ; Passeto AS; Vilela MM
AIDS; 2011 Nov; 25(17):2079-87. PubMed ID: 21866040
[TBL] [Abstract][Full Text] [Related]
8. Mycobacterium bovis BCG Vaccination Induces Divergent Proinflammatory or Regulatory T Cell Responses in Adults.
Boer MC; Prins C; van Meijgaarden KE; van Dissel JT; Ottenhoff TH; Joosten SA
Clin Vaccine Immunol; 2015 Jul; 22(7):778-88. PubMed ID: 25947145
[TBL] [Abstract][Full Text] [Related]
9. Lymph node targeting of BCG vaccines amplifies CD4 and CD8 T-cell responses and protection against Mycobacterium tuberculosis.
Waeckerle-Men Y; Bruffaerts N; Liang Y; Jurion F; Sander P; Kündig TM; Huygen K; Johansen P
Vaccine; 2013 Feb; 31(7):1057-64. PubMed ID: 23273509
[TBL] [Abstract][Full Text] [Related]
10. Attrition of T-cell functions and simultaneous upregulation of inhibitory markers correspond with the waning of BCG-induced protection against tuberculosis in mice.
Nandakumar S; Kannanganat S; Posey JE; Amara RR; Sable SB
PLoS One; 2014; 9(11):e113951. PubMed ID: 25419982
[TBL] [Abstract][Full Text] [Related]
11. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
12. [Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Wagner R; Mayer J; Wolf H
Dtsch Med Wochenschr; 1995 May; 120(20):728-36. PubMed ID: 7758413
[No Abstract] [Full Text] [Related]
13. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
14. HIV as an inflammatory disease.
Smith D
J HIV Ther; 2009 Nov; 14(3):50-1. PubMed ID: 20218238
[No Abstract] [Full Text] [Related]
15. [Tuberculosis: molecular genetic BCG vaccine preparation].
Pneumologie; 1997 Aug; 51(8):XIV. PubMed ID: 9380655
[No Abstract] [Full Text] [Related]
16. [Immunobiology of HIV infection].
Hattori T
Uirusu; 2002 Dec; 52(2):245-9. PubMed ID: 12685315
[No Abstract] [Full Text] [Related]
17. Accelerating the secondary immune response by inactivating CD4(+)CD25(+) T regulatory cells prior to BCG vaccination does not enhance protection against tuberculosis.
Quinn KM; Rich FJ; Goldsack LM; de Lisle GW; Buddle BM; Delahunt B; Kirman JR
Eur J Immunol; 2008 Mar; 38(3):695-705. PubMed ID: 18266274
[TBL] [Abstract][Full Text] [Related]
18. Early CD4+ T Cell Responses Are Associated with Subsequent CD8+ T Cell Responses to an rAd5-Based Prophylactic Prime-Boost HIV Vaccine Strategy.
Lhomme E; Richert L; Moodie Z; Pasin C; Kalams SA; Morgan C; Self S; De Rosa SC; Thiébaut R
PLoS One; 2016; 11(4):e0152952. PubMed ID: 27124598
[TBL] [Abstract][Full Text] [Related]
19. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis A vaccination and immunological parameters in HIV-infected patients.
Kourkounti S; Papaizos V; Leuow K; Kordosis T; Antoniou C
Viral Immunol; 2013 Oct; 26(5):357-63. PubMed ID: 24044625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
